Obesity and its associated Metabolic Syndromes (Mets) represent a global epidemic health
problem. Metabolic inflammation, lipid accumulation and insulin resistance contribute to the …

Since time immemorial, humans have coevolved with a wide variety of parasitic helminths
that have contributed to shape their immune system. The recent eradication of helminth …

Parasitic helminths have coexisted with human beings throughout time. Success in
eradicating helminths has limited helminth-induced morbidity and mortality but is also …

Obesity is a worldwide pandemic and major risk factor for the development of metabolic
syndrome (MetS) and type 2 diabetes (T2D). T2D requires lifelong medical support to limit …

Type 2 immunity has recently emerged as a critical player in metabolic status, with
numerous studies investigating the role of type 2 immune cells within adipose tissue …

Epidemiological studies indicate an inverse correlation between the prevalence of the so-
called western diseases, such as obesity and metabolic syndrome, and the exposure to …

About one-fourth of the global population is either overweight or obese, both of which
increase the risk of insulin resistance, cardiovascular diseases, and infections. In obesity …

Chronic low-grade inflammation associated with obesity contributes to insulin resistance
and type 2 diabetes. Helminth parasites are the strongest natural inducers of type 2 immune …

Worldwide, there is little overlap between the prevalence of soil‐transmitted helminths and
type 2 diabetes (T2D). Helminth‐induced type 2 immune responses and immune regulatory …

Background & Aims Epidemiological and animal studies have indicated an inverse
correlation between the rising prevalence of obesity and metabolic syndrome and exposure …